Inventor · disambiguated record
Kennan C. Marsh
Also filed as: MARSH KENNAN · MARSH KENNAN C
17 granted patents·16 pending applications·547 citations·filing 1994–2016
94Inventor score
Top patents by PatentIndex Score
33 records- 0194US5484801APharmaceutical composition for inhibiting HIV proteaseABBOTT LAB·Filed 1995·Granted Jan 16, 1996·193 cites·28 claims
- 0292US5948436APharmaceutical compositionABBOTT LAB·Filed 1995·Granted Sep 7, 1999·100 cites·44 claims
- 0388US5725878APharmaceutical composition comprising HIV protease inhibiting compoundsABBOTT LAB·Filed 1995·Granted Mar 10, 1998·76 cites·4 claims
- 0485US5559158APharmaceutical compositionABBOTT LAB·Filed 1994·Granted Sep 24, 1996·78 cites·16 claims
- 0581US5610193APharmaceutical compositionABBOTT LAB·Filed 1996·Granted Mar 11, 1997·61 cites·3 claims
- 0678US6911214B2Flavoring systems for pharmaceutical compositions and methods of making such compositionsABBOTT LAB·Filed 2001·Granted Jun 28, 2005·6 cites·1 claims
- 0776US8232309B2Prodrugs of compounds that inhibit TRPV1 receptorGOMTSYAN ARTHUR R·Filed 2006·Granted Jul 31, 2012·2 cites·22 claims
- 0874US2010081715A1Formulation Comprising Fenofibric Acid, A Physiologically Acceptable Salt or Derivative ThereofROSENBERG JOERG·Filed 2009·Application pending·0 cites
- 0972US10072040B2Tylosin A analogs and derivativesABBVIE INC·Filed 2015·Granted Sep 11, 2018·1 cites·33 claims
- 1071US8026240B2Octahydro-pyrrolo[3,4-b]pyrrole N-oxidesABBOTT LAB·Filed 2008·Granted Sep 27, 2011·2 cites·7 claims
- 1170US8501219B2Flavoring systems for pharmaceutical compositions and methods of making such compositionsALANI LAMAN·Filed 2010·Granted Aug 6, 2013·2 cites·29 claims
- 1268US8895051B2Flavoring systems for pharmaceutical compositions and methods of making such compositionsABBVIE INC·Filed 2013·Granted Nov 25, 2014·0 cites·31 claims
- 1365US9078921B2Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing sameRosenberg Jörg·Filed 2007·Granted Jul 14, 2015·1 cites·20 claims
- 1462US2006134196A1Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereofABBOTT GMBH & CO KG·Filed 2003·Application pending·0 cites
- 1561US6193954B1Formulations for pulmonary delivery of dopamine agonistsABBOTT LAB·Filed 1997·Granted Feb 27, 2001·23 cites·31 claims
- 1661US2012178808A1Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereofROSENBERG JOERG·Filed 2012·Application pending·0 cites
- 1760US2007077307A1Pharmaceutical compositionsROSENBERG JOERG·Filed 2006·Application pending·0 cites
- 1860US2012046360A1Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereofROSENBERG JOERG·Filed 2011·Application pending·0 cites
- 1958US2007049636A1Pharmaceutical compositionsROSENBERG JOERG·Filed 2005·Application pending·0 cites
- 2055US2005191324A1Flavoring systems for pharmaceutical compositions and methods of making such compositionsFiled 2005·Application pending·0 cites
- 2152US2007048384A1Pharmaceutical compositionsROSENBERG JOERG·Filed 2006·Application pending·0 cites
- 2252US2007207122A1Compositons and methods of use of ritonavir for treating hcvKEMPF DALE J·Filed 2007·Application pending·0 cites
- 2349US8901157B2Compositions and methods of use of ritonavir for treating HCVKEMPF DALE J·Filed 2010·Granted Dec 2, 2014·0 cites·5 claims
- 2448US2012277190A1Prodrugs of compounds that inhibit trpv1 receptorGOMTSYAN ARTHUR R·Filed 2012·Application pending·0 cites
- 2547US9616130B2Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing sameABBVIE DEUTSCHLAND·Filed 2015·Granted Apr 11, 2017·0 cites·20 claims
- 2640US10238677B2Treatment of filarial diseasesABBVIE INC·Filed 2016·Granted Mar 26, 2019·0 cites·28 claims
- 2740US2007104780A1Formulation comprising a drug of low water solubility and method of use thereofLIPARI JOHN M·Filed 2006·Application pending·0 cites
- 2838US2016200757A1Tylosin a analogs and derivativesABBVIE INC·Filed 2016·Application pending·0 cites
- 2937US2010297194A1Formulation for oral administration of apoptosis promoterCATRON NATHANIEL·Filed 2010·Application pending·0 cites
- 3036US2010323020A1Stable nanoparticulate drug suspensionABBOTT LAB·Filed 2010·Application pending·0 cites
- 3136US2010278921A1Solid oral formulation of abt-263FISCHER CRISTINA M·Filed 2010·Application pending·0 cites
- 3234US5876749APharmaceutical compositionABBOTT LAB·Filed 1995·Granted Mar 2, 1999·2 cites·13 claims
- 3331US2010280031A1Lipid formulation of apoptosis promoterDAVID PAUL·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kennan C. Marsh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →